Clinical Trial Update: CRAFT: The NCT-PMO-1602 Phase II Trial [Phase 2]

View source ↗

Summary

This is an update reporting the completion of the NCT-PMO-1602 Phase II trial (CRAFT) conducted by the German Cancer Research Center in patients with metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: German Cancer Research Center | Conditions: Metastatic or Locally Advanced Malignancies | Phase 2 | Status: COMPLETED